Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12065637 Scheduled feed

Patent 12065637 was granted and assigned to Terumo BCT on August, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Terumo BCT
Terumo BCT
0
Date Filed
April 14, 2023
0
Date of Patent
August 20, 2024
0
Patent Applicant
Terumo BCT
Terumo BCT
0
Patent Application Number
18300427
0
Patent Citations
‌
US Patent 6841386 Modulation of primary stem cell differentiation using an insulin-like growth factor binding protein
0
‌
US Patent 6841542 Transforming growth factor beta (TGF-β) blocking agent-treated stem cell composition and method
0
‌
US Patent 6844011 Methods for inhibiting rejection of transplanted tissue
0
‌
US Patent 6849051 Devices and methods for extraction of bone marrow
0
‌
US Patent 6849255 Methods and compositions for enhancing cartilage repair
0
‌
US Patent 6849454 Highly efficient gene transfer into human repopulating stem cells by RD114 pseudotyped retroviral vector particles
0
‌
US Patent 6849662 Therapeutic uses for nitric oxide inhibitors
0
‌
US Patent 6852308 Radio-opaque polymeric biomaterials
0
‌
US Patent 6852321 Lectin-derived progenitor cell preservation factor and methods of use
0
‌
US Patent 6852533 Purified populations of stem cells
0
•••
Patent Inventor Names
Boah Vang
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12065637
0
Patent Primary Examiner
‌
David W Berke-Schlessel
0

Find more entities like US Patent 12065637 Scheduled feed

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.